INS and plasma cell myeloma: Anti-insulin IgG3-lambda monoclonal antibody distinct from the primary myeloma clone monoclonal IgG3-kappa. Elevated anti-insulin antibody titers and hypoglycemic attacks were closely associated with escape of myeloma from suppression by therapy